Stereotaxis share price today

(STXS)

Stereotaxis share price is $2.08 & ₹179.95 as on 14 Jan 2025, 2.30 'hrs' IST

$2.08

▲

-0.03

(-1.42%)

Market is closed - opens 8 PM, 14 Jan 2025

View live Stereotaxis share price in Dollar and Rupees. Guide to invest in Stereotaxis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Stereotaxis, along with analyst recommendations, forecasts, and comprehensive financials.

Stereotaxis share price movements

Today's Low: $2.03
Today's High: $2.12
$2.08
2.4%
Downside
Day's Volatility :4.09%
Upside
1.72%
52 Weeks Low: $1.66
52 Weeks High: $3.29
$2.08
20.19%
Downside
52 Weeks Volatility :49.54%
Upside
36.78%

Stereotaxis Returns

Period	Stereotaxis Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	9.47%	-8.6%	0.0%
6 Months	-1.42%	-4.6%	0.0%
1 Year	14.29%	0.7%	0.0%
3 Years	-61.19%	5.5%	-18.2%

Stereotaxis Key Statistics

in dollars & INR

Previous Close	$2.11
Open	$2.05
Today's High	$2.1165
Today's Low	$2.03
Market Capitalization	$178.8M
Today's Volume	$272.5K
52 Week High	$3.29
52 Week Low	$1.66
Revenue TTM	$25.1M
EBITDA	$-21.9M
Earnings Per Share (EPS)	$-0.27
Profit Margin	-85.79%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-106.46%

How to invest in Stereotaxis from India?

It is very easy for Indian residents to invest directly in Stereotaxis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Stereotaxis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Stereotaxis or STXS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Stereotaxis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Stereotaxis shares which would translate to 0.416 fractional shares of Stereotaxis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Stereotaxis, in just a few clicks!

Returns in Stereotaxis for Indian investors in Rupees

Investment Value

₹1,00,000

Stereotaxis investment value today

Current value as on today

₹1,18,668

Returns

₹18,668

(+18.67%)

Returns from Stereotaxis Stock

₹14,286 (+14.29%)

Dollar Returns

₹4,382 (+4.38%)

Indian investors sentiment towards Stereotaxis

-15%

Period: Oct 15, 2024 to Jan 13, 2025. Change in 30 Days versus previous period

Search volume for Stereotaxis on INDmoney from India has reduced in the last 30 days as on Jan 14, 2025. -15% less investors are searching Stereotaxis in the last 30 days versus the previous period.

Analyst Recommendation on Stereotaxis

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Stereotaxis(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Stereotaxis

What analysts predicted

Upside of 116.35%

Target:

$4.50

Current:

$2.08

Insights on Stereotaxis

Price Movement
In the last 7 days, STXS stock has moved down by -13.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 4.50M → 9.19M (in $), with an average increase of 51.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -4.50M → -6.19M (in $), with an average decrease of 17.8% per quarter
STXS vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 48.4% return, outperforming this stock by 36.6%
STXS vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 75.4% return, outperforming this stock by 139.1%
Price to Sales
ForSTXS every $1 of sales, investors are willing to pay $7.0, whereas for Intuitive Surgical, Inc., the investors are paying $24.3 for every $1 of sales.

Stereotaxis Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$29.3M	↓ 5.77%
Net Income	$116.8K	↓ 101.98%
Net Profit Margin	0.4%	↑ 19.3%

	FY19	Y/Y Change
Revenue	$28.9M	↓ 1.51%
Net Income	$-4.2M	↓ 3725.49%
Net Profit Margin	-14.65%	↓ 15.05%

	FY20	Y/Y Change
Revenue	$26.6M	↓ 7.86%
Net Income	$-6.5M	↑ 52.44%
Net Profit Margin	-24.23%	↓ 9.58%

	FY21	Y/Y Change
Revenue	$35.0M	↑ 31.51%
Net Income	$-8.4M	↑ 30.75%
Net Profit Margin	-24.09%	↑ 0.14%

	FY22	Y/Y Change
Revenue	$28.1M	↓ 19.63%
Net Income	$-19.2M	↑ 126.98%
Net Profit Margin	-68.04%	↓ 43.95%

	FY23	Y/Y Change
Revenue	$26.8M	↓ 4.89%
Net Income	$-20.7M	↑ 8.16%
Net Profit Margin	-77.37%	↓ 9.33%

	Q2 FY23	Q/Q Change
Revenue	$7.9M	↑ 20.02%
Net Income	$-5.0M	↑ 0.85%
Net Profit Margin	-63.07%	↑ 11.99%

	Q3 FY23	Q/Q Change
Revenue	$7.8M	↓ 0.76%
Net Income	$-5.7M	↑ 15.13%
Net Profit Margin	-73.18%	↓ 10.11%

	Q4 FY23	Q/Q Change
Revenue	$4.6M	↓ 41.47%
Net Income	$-5.0M	↓ 11.69%
Net Profit Margin	-110.41%	↓ 37.23%

	Q1 FY24	Q/Q Change
Revenue	$6.9M	↑ 50.71%
Net Income	$-4.5M	↓ 10.58%
Net Profit Margin	-65.51%	↑ 44.9%

	Q2 FY24	Q/Q Change
Revenue	$4.5M	↓ 34.56%
Net Income	$-5.8M	↑ 29.42%
Net Profit Margin	-129.56%	↓ 64.05%

	Q3 FY24	Q/Q Change
Revenue	$9.2M	↑ 104.26%
Net Income	$-6.2M	↑ 6.12%
Net Profit Margin	-67.31%	↑ 62.25%

	FY18	Y/Y Change
Profit	$23.6M	↑ 15.89%

	FY19	Y/Y Change
Profit	$22.8M	↓ 3.65%

	FY20	Y/Y Change
Profit	$19.0M	↓ 16.69%

	FY21	Y/Y Change
Profit	$23.2M	↑ 22.49%

	FY22	Y/Y Change
Profit	$18.5M	↓ 20.5%

	FY23	Y/Y Change
Profit	$14.9M	↓ 19.55%

	Q2 FY23	Q/Q Change
Profit	$4.2M	↑ 8.02%

	Q3 FY23	Q/Q Change
Profit	$4.1M	↓ 3.06%

	Q4 FY23	Q/Q Change
Profit	$2.7M	↓ 32.54%

	Q1 FY24	Q/Q Change
Profit	$4.0M	↑ 44.85%

	Q2 FY24	Q/Q Change
Profit	$3.3M	↓ 16.46%

	Q3 FY24	Q/Q Change
Profit	$4.1M	↑ 23.72%

	FY18	Y/Y Change
Operating Cash Flow	$-2.5M	↓ 45.52%
Investing Cash Flow	$-265.5K	↑ 225.44%
Financing Cash Flow	$9.9M	↓ 16932.07%

	FY19	Y/Y Change
Operating Cash Flow	$-4.6M	↑ 81.29%
Investing Cash Flow	$-29.5K	↓ 88.89%
Financing Cash Flow	$24.0M	↑ 142.22%

	FY20	Y/Y Change
Operating Cash Flow	$-3.5M	↓ 23.93%
Investing Cash Flow	$-70.9K	↑ 140.44%
Financing Cash Flow	$17.3M	↓ 27.85%

	FY21	Y/Y Change
Operating Cash Flow	$-2.9M	↓ 16.11%
Investing Cash Flow	$-1.4M	↑ 1869.91%
Financing Cash Flow	$547.4K	↓ 96.84%

	FY22	Y/Y Change
Operating Cash Flow	$-8.4M	↑ 185.65%
Investing Cash Flow	$-22.1M	↑ 1482.0%
Financing Cash Flow	$220.0K	↓ 59.81%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-2.9M	↑ 4.6%
Investing Cash Flow	$20.1M	↓ 5866.19%
Financing Cash Flow	$-26.0K	↓ 146.43%

Stereotaxis Technicals Summary

Sell

Neutral

Buy

Stereotaxis is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Stereotaxis Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Stereotaxis Inc	-14.05%	-1.42%	14.29%	-61.19%	-60.0%
Intuitive Surgical, Inc.	-0.41%	23.23%	48.97%	82.66%	170.65%
Alcon Ag	-0.57%	-7.61%	6.45%	7.03%	36.28%
West Pharmaceutical Services Inc	2.73%	3.19%	-1.99%	-8.75%	114.45%
Resmed Inc.	-4.46%	11.34%	35.28%	-4.33%	43.26%
Becton, Dickinson And Company	3.79%	2.38%	0.51%	-9.3%	-14.69%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Stereotaxis Inc	NA	NA	0.0	-0.27	-1.06	-0.29	NA	0.13
Intuitive Surgical, Inc.	87.74	87.76	4.0	6.87	0.16	0.08	NA	43.75
Alcon Ag	35.65	35.64	3.04	3.03	0.06	0.03	0.0	43.25
West Pharmaceutical Services Inc	49.29	49.29	6.34	6.66	0.18	0.1	0.0	37.96
Resmed Inc.	31.05	31.07	1.75	9.34	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	39.81	39.81	1.07	14.37	0.06	0.03	0.02	89.47

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Stereotaxis Inc	Buy	$178.8M	-60.0%	NA	-85.79%
Intuitive Surgical, Inc.	Buy	$195.0B	170.65%	87.74	28.51%
Alcon Ag	Buy	$41.7B	36.28%	35.65	11.89%
West Pharmaceutical Services Inc	Buy	$24.0B	114.45%	49.29	17.37%
Resmed Inc.	Buy	$34.3B	43.26%	31.05	23.15%
Becton, Dickinson And Company	Buy	$67.8B	-14.69%	39.81	7.13%

About Stereotaxis

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Organization	Stereotaxis
Employees	122
CEO	Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
Industry	Medical Specialties

Management People of Stereotaxis

Name	Title
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.	CEO & Chairman
Ms. Kimberly R. Peery CPA	CFO & Secretary
Mr. Keith Galloway	Vice President of Operations

Important FAQs about investing in Stereotaxis from India :

What is Stereotaxis share price today?

Stereotaxis share price today stands at $2.08, Open: $2.05 ; Previous Close: $2.11 ; High: $2.12 ; Low: $2.03 ; 52 Week High: $3.29 ; 52 Week Low: $1.66. The stock opens at $2.05, after a previous close of $2.11. The stock reached a daily high of $2.12 and a low of $2.03, with a 52-week high of $3.29 and a 52-week low of $1.66.

Can Indians buy Stereotaxis shares?

Yes, Indians can invest in the Stereotaxis (STXS) from India.

With INDmoney, you can buy Stereotaxis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Stereotaxis at zero transaction cost.

How can I buy Stereotaxis shares from India?

It is very easy to buy Stereotaxis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Stereotaxis be purchased?

Yes, you can buy fractional shares of Stereotaxis with INDmoney app.

What are the documents required to start investing in Stereotaxis stocks?

To start investing in Stereotaxis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.